Sony Corporation and WS Audiology’s joint project to launch OTC products is over. The Denmark-based multinational, WSA, has confirmed that both outfits “have mutually agreed not to renew their 2022 agreement”. Sony has issued no official comment on the end of the affair....
✦ Clinical Takeaway ✦
No actionable change — this is a business partnership dissolution with no direct impact on clinical practice.
✦ Why It Matters ✦
The exit signals continued challenges for major consumer electronics brands attempting to establish themselves in the OTC hearing aid market.
✦ Key Points ✦
- 01WS Audiology and Sony have mutually ended their OTC hearing product partnership.
- 02Both the Anshin and Kando products are discontinued.
- 03The partnership originally launched in 2022 to target the OTC hearing market.
- 04Neither company has announced a replacement product or successor agreement.
✦ Claims & Evidence ✦
ClaimEvidenceSupport
WS Audiology and Sony mutually agreed not to renew their OTC hearing product partnership.
press releasesupportedBoth the Anshin and Kando OTC hearing products have been discontinued.
press releasesupported
